JP2023502940A5 - - Google Patents

Info

Publication number
JP2023502940A5
JP2023502940A5 JP2022528026A JP2022528026A JP2023502940A5 JP 2023502940 A5 JP2023502940 A5 JP 2023502940A5 JP 2022528026 A JP2022528026 A JP 2022528026A JP 2022528026 A JP2022528026 A JP 2022528026A JP 2023502940 A5 JP2023502940 A5 JP 2023502940A5
Authority
JP
Japan
Prior art keywords
seq
lysin
polypeptide
sequence number
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/060389 external-priority patent/WO2021097192A1/en
Publication of JP2023502940A publication Critical patent/JP2023502940A/ja
Publication of JP2023502940A5 publication Critical patent/JP2023502940A5/ja
Pending legal-status Critical Current

Links

JP2022528026A 2019-11-14 2020-11-13 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用 Pending JP2023502940A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962935479P 2019-11-14 2019-11-14
US62/935,479 2019-11-14
PCT/US2020/060389 WO2021097192A1 (en) 2019-11-14 2020-11-13 Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Publications (2)

Publication Number Publication Date
JP2023502940A JP2023502940A (ja) 2023-01-26
JP2023502940A5 true JP2023502940A5 (cg-RX-API-DMAC7.html) 2023-11-20

Family

ID=75912341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528026A Pending JP2023502940A (ja) 2019-11-14 2020-11-13 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Country Status (4)

Country Link
US (1) US20220411473A1 (cg-RX-API-DMAC7.html)
EP (1) EP4058468A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023502940A (cg-RX-API-DMAC7.html)
WO (1) WO2021097192A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010071A (es) * 2018-03-29 2021-01-08 Contrafect Corp Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.
WO2023081913A1 (en) * 2021-11-08 2023-05-11 Emory University Wild boar cathelicidin peptide variants and vectors encoding the same for uses in managing coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2699689A4 (en) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES
US9518252B2 (en) * 2011-05-26 2016-12-13 Dsm Ip Assets B.V. Listeria bacteriophage P825 and uses thereof
US8790639B2 (en) * 2012-03-28 2014-07-29 The United States Of America, As Represented By The Secretary Of Agriculture Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
BR112020011433A2 (pt) * 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
US10988520B2 (en) * 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
WO2019191633A2 (en) * 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
MX2020010071A (es) * 2018-03-29 2021-01-08 Contrafect Corp Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.

Similar Documents

Publication Publication Date Title
JP2021533728A5 (cg-RX-API-DMAC7.html)
US12144845B2 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
JP2021519083A5 (cg-RX-API-DMAC7.html)
JP2024010053A5 (cg-RX-API-DMAC7.html)
IL277119B2 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP2021506769A5 (cg-RX-API-DMAC7.html)
JP6483058B2 (ja) 抗菌剤と分散剤または接着阻害剤組成物
IL313959A (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
Gawande et al. Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria
JP2024010053A (ja) シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定
Khan et al. Antibiotics application strategies to control biofilm formation in pathogenic bacteria
Dua et al. Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?
Naseef Pathoor et al. Understanding the biofilm development of Acinetobacter baumannii and novel strategies to combat infection
JP2021527699A (ja) 溶解素及びその誘導体がスタフィロコッカス・アウレウス及びグラム陽性細菌を抗生物質に再感作する
Jalil et al. The use of combination therapy for the improvement of colistin activity against bacterial biofilm
Łusiak-Szelachowska et al. Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis.
JP2021508501A (ja) Pseudomonas感染症を処置するためのバクテリオファージ組成物
RU2646798C2 (ru) Антибактериальные композиции
US9078859B2 (en) Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
JP2022526978A5 (cg-RX-API-DMAC7.html)
RU2020129478A (ru) Полипептидные конструкции лизин-противомикробный пептид (amp), лизины, выделенные полинуклеотиды, кодирующие их, а также варианты их применения
HK40086790A (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
RU2020131450A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий
US12606640B2 (en) Recombinant antimicrobial multidomain polypeptide, methods of producing and uses thereof
de Oliveira Costa et al. Therapeutic options for treatment of infections by pathogenic biofilms